Back to SYRE
VANGUARD CAPITAL MANAGEMENT LLC → SYRE
VANGUARD CAPITAL MANAGEMENT LLC SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$333.9M
Q3 2026
Peak value
$333.9M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $154.2M |
| Q1 2026 | $154.2M |
| Q2 2026 | $306.2M |
| Q3 2026 | $333.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $333.9M | 3.75M | — | — |
| Q2 2026 | $306.2M | 3.45M | — | — |
| Q1 2026 | $154.2M | 3.06M | — | — |
| Q1 2026 | $154.2M | 3.06M | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$383.5M
$377.5M
$348.1M